Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Matthijs

Showing results (101-110 of 294) with videos related to

Pageof 30
Sort By:
European Heart Journal|April 1, 2025
Low-density lipoprotein cholesterol, C-reactive protein, and lipoprotein(a) universal one-time screening in primary prevention: the EPIC-Norfolk studyJordan M Kraaijenhof, Nick S Nurmohamed, Ask T Nordestgaard, et al.
European Journal of Clinical Investigation|July 18, 2013
Non-HDL cholesterol vs. apo B for risk of coronary heart disease in healthy individuals: the EPIC-Norfolk prospective population studyBrigitte M Sondermeijer, Jamal S Rana, Benoit J Arsenault, et al.
Journal of the American College of Cardiology|July 15, 2017
Community-Based Lifestyle Intervention in Patients With Coronary Artery Disease: The RESPONSE-2 TrialMadelon Minneboo, Sangeeta Lachman, Marjolein Snaterse, et al.
American Heart Journal|February 24, 2021
Plasma trimethylamine N-oxide (TMAO) levels predict future risk of coronary artery disease in apparently healthy individuals in the EPIC-Norfolk prospective population studyW H Wilson Tang, Xinmin S Li, Yuping Wu, et al.
American Heart Journal|May 15, 2018
The prognostic value of heart rate recovery in patients with coronary artery disease: A systematic review and meta-analysisSangeeta Lachman, Michel S Terbraak, Jacqueline Limpens, et al.
Circulation|April 6, 2018
Triglyceride-Rich Lipoprotein Cholesterol and Risk of Cardiovascular Events Among Patients Receiving Statin Therapy in the TNT TrialAntonio J Vallejo-Vaz, Rana Fayyad, S Matthijs Boekholdt, et al.
The American Journal of Cardiology|March 4, 2014
Impact of high-dose atorvastatin therapy and clinical risk factors on incident aortic valve stenosis in patients with cardiovascular disease (from TNT, IDEAL, and SPARCL)Benoit J Arsenault, S Matthijs Boekholdt, Samia Mora, et al.
Clinical Chemistry|March 30, 2010
Comparison between gradient gel electrophoresis and nuclear magnetic resonance spectroscopy in estimating coronary heart disease risk associated with LDL and HDL particle sizeBenoit J Arsenault, Isabelle Lemieux, Jean-Pierre Després, et al.
European Journal of Preventive Cardiology|September 5, 2013
The Systematic COronary Risk Evaluation (SCORE) in a large UK population: 10-year follow-up in the EPIC-Norfolk prospective population studyHarald T Jørstad, Ersen B Colkesen, Madelon Minneboo, et al.
Atherosclerosis|November 9, 2023
Tryptophan metabolites and incident cardiovascular disease: The EPIC-Norfolk prospective population studyCharlotte J Teunis, Erik S G Stroes, S Matthijs Boekholdt, et al.
Pageof 30

Showing results (101-110 of 294) with videos related to

Sort By:
Pageof 30
European Heart Journal|April 1, 2025
Low-density lipoprotein cholesterol, C-reactive protein, and lipoprotein(a) universal one-time screening in primary prevention: the EPIC-Norfolk studyJordan M Kraaijenhof, Nick S Nurmohamed, Ask T Nordestgaard, et al.
European Journal of Clinical Investigation|July 18, 2013
Non-HDL cholesterol vs. apo B for risk of coronary heart disease in healthy individuals: the EPIC-Norfolk prospective population studyBrigitte M Sondermeijer, Jamal S Rana, Benoit J Arsenault, et al.
Journal of the American College of Cardiology|July 15, 2017
Community-Based Lifestyle Intervention in Patients With Coronary Artery Disease: The RESPONSE-2 TrialMadelon Minneboo, Sangeeta Lachman, Marjolein Snaterse, et al.
American Heart Journal|February 24, 2021
Plasma trimethylamine N-oxide (TMAO) levels predict future risk of coronary artery disease in apparently healthy individuals in the EPIC-Norfolk prospective population studyW H Wilson Tang, Xinmin S Li, Yuping Wu, et al.
American Heart Journal|May 15, 2018
The prognostic value of heart rate recovery in patients with coronary artery disease: A systematic review and meta-analysisSangeeta Lachman, Michel S Terbraak, Jacqueline Limpens, et al.
Circulation|April 6, 2018
Triglyceride-Rich Lipoprotein Cholesterol and Risk of Cardiovascular Events Among Patients Receiving Statin Therapy in the TNT TrialAntonio J Vallejo-Vaz, Rana Fayyad, S Matthijs Boekholdt, et al.
The American Journal of Cardiology|March 4, 2014
Impact of high-dose atorvastatin therapy and clinical risk factors on incident aortic valve stenosis in patients with cardiovascular disease (from TNT, IDEAL, and SPARCL)Benoit J Arsenault, S Matthijs Boekholdt, Samia Mora, et al.
Clinical Chemistry|March 30, 2010
Comparison between gradient gel electrophoresis and nuclear magnetic resonance spectroscopy in estimating coronary heart disease risk associated with LDL and HDL particle sizeBenoit J Arsenault, Isabelle Lemieux, Jean-Pierre Després, et al.
European Journal of Preventive Cardiology|September 5, 2013
The Systematic COronary Risk Evaluation (SCORE) in a large UK population: 10-year follow-up in the EPIC-Norfolk prospective population studyHarald T Jørstad, Ersen B Colkesen, Madelon Minneboo, et al.
Atherosclerosis|November 9, 2023
Tryptophan metabolites and incident cardiovascular disease: The EPIC-Norfolk prospective population studyCharlotte J Teunis, Erik S G Stroes, S Matthijs Boekholdt, et al.
Pageof 30